Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pliant Therapeutics (PLRX) Return on Equity (2020 - 2025)

Historic Return on Equity for Pliant Therapeutics (PLRX) over the last 6 years, with Q3 2025 value amounting to 0.83%.

  • Pliant Therapeutics' Return on Equity fell 2900.0% to 0.83% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.83%, marking a year-over-year decrease of 2900.0%. This contributed to the annual value of 0.54% for FY2024, which is 1300.0% down from last year.
  • Per Pliant Therapeutics' latest filing, its Return on Equity stood at 0.83% for Q3 2025, which was down 2900.0% from 0.87% recorded in Q2 2025.
  • Pliant Therapeutics' Return on Equity's 5-year high stood at 0.26% during Q2 2023, with a 5-year trough of 0.87% in Q2 2025.
  • Moreover, its 5-year median value for Return on Equity was 0.45% (2024), whereas its average is 0.49%.
  • Its Return on Equity has fluctuated over the past 5 years, first skyrocketed by 4200bps in 2023, then tumbled by -4200bps in 2025.
  • Pliant Therapeutics' Return on Equity (Quarter) stood at 0.46% in 2021, then rose by 18bps to 0.38% in 2022, then increased by 13bps to 0.33% in 2023, then tumbled by -96bps to 0.65% in 2024, then dropped by -29bps to 0.83% in 2025.
  • Its Return on Equity was 0.83% in Q3 2025, compared to 0.87% in Q2 2025 and 0.78% in Q1 2025.